Ocumetics Announces Enhancements to Lens Delivery System Following First-in-Human Procedures

Ocumetics Technology announced that Medicel AG, a provider of ophthalmic device delivery systems, has implemented modifications to its lens delivery technology in response to surgeon feedback from recent first-in-human implantation procedures.

The adjustments follow insights from the surgeon who performed the company’s initial human implantations—input that Ocumetics says is already shaping critical refinements to the Ocumetics Lens platform.

“The surgeon who performed our first-in-human implantations has been instrumental in shaping further improvements in the design of our lens delivery system that will be invaluable as we work to optimize the final configuration of the Ocumetics Lens,” said Dean Burns, President and CEO of Ocumetics. “Medicel’s willingness to innovate rapidly and refine their delivery platform for the Ocumetics Lens based on surgeon feedback demonstrates the strength of our partnership and Medicel’s commitment to supporting next-generation accommodating intraocular lens technologies.”

According to the company, the updated IOL delivery system has been engineered to improve loading efficiency, streamline implantation steps, and ensure optimal compatibility with the mechanical characteristics of the Ocumetics Lens. These enhancements are intended to facilitate smoother insertion and further increase surgeon confidence as the platform moves toward broader clinical evaluation.

Ocumetics plans to utilize the optimized delivery system for its upcoming Group 2 surgeries, anticipated to begin in early 2026.